Company Filing History:
Years Active: 2022
Title: Innovator Xin Lu: Pioneering Embolism Materials of the Future
Introduction
Xin Lu, an inventor based in Hubei, China, has made significant contributions to the field of medical materials with his innovative patent. With a focus on embolism materials for blood vessels, he has developed a solution that promises to enhance embolization therapies for tumors.
Latest Patents
Xin Lu holds a patent titled "Embolism material for blood vessel, preparation method therefor and use thereof in preparation of drugs." This patent introduces the use of poly(N-isopropylacrylamide-co-butyl methacrylate) in the formulation of an embolism material. The material is designed to assist in medical treatments, especially in the context of hypervascular and parenchymal visceral organs. The composition includes a dispersion medium that consists of an electrolyte, a contrast agent, a pH regulator, and water, with specified concentrations for optimal effectiveness.
Career Highlights
Xin Lu is associated with Anew-med Life Science (Wuhan) Co., Ltd., where he actively engages in innovative research and development projects. His work focuses on creating advanced medical materials that can improve treatment outcomes in clinical settings. This single patent showcases his dedication to improving medical technologies and patient care through research and innovation.
Collaborations
At Anew-med Life Science, Xin collaborates with notable colleagues, including Haixia Sun and Hong Liu. Together, they contribute to the advancement of medical materials and therapies, working cohesively to push the boundaries of innovation in their field.
Conclusion
Xin Lu's innovative spirit and dedication to developing embolism materials mark him as a significant figure in medical research. His patent not only showcases his inventive prowess but also underscores the importance of collaboration in driving advancements in healthcare. As the medical field continues to evolve, inventions like those of Xin Lu pave the way for improved treatment options and better patient outcomes.